share_log

The Total Return for Shandong Wit Dyne HealthLtd (SZSE:000915) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years

The Total Return for Shandong Wit Dyne HealthLtd (SZSE:000915) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years

在过去的五年中,山东围海健康产业股份有限公司(SZSE:000915)的总回报增长速度比盈利增长速度更快。
Simply Wall St ·  06/20 18:42

While Shandong Wit Dyne Health Co.,Ltd. (SZSE:000915) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 11% in the last quarter. But that doesn't change the fact that the returns over the last five years have been pleasing. Its return of 52% has certainly bested the market return!

尽管山东华特达因健康股份有限公司(SZSE:000915)的股东可能普遍感到高兴,但股票近期表现不佳,股价在上季度下跌了11%。但这并没有改变过去五年的回报令人满意的事实。其回报率为52%,肯定高于市场回报!

While this past week has detracted from the company's five-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.

虽然过去的一周削弱了公司的五年回报,但让我们看看业务的最近趋势,并查看收益是否已对齐。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

市场有时无疑是高效的,但价格并不总是反映基础业务表现。 一种检查市场情绪如何随时间改变的方法是查看公司的股价与每股收益(EPS)之间的互动。

During five years of share price growth, Shandong Wit Dyne HealthLtd achieved compound earnings per share (EPS) growth of 50% per year. The EPS growth is more impressive than the yearly share price gain of 9% over the same period. So one could conclude that the broader market has become more cautious towards the stock.

在五年的股价增长中,山东华特达因健康股份有限公司的复合每股收益(EPS)增长率为每年50%。EPS的增长比相同期间每股股价上涨9%更令人印象深刻。因此,可以得出结论,市场整体对该股变得更加谨慎。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下图显示了EPS随时间变化的情况(点击图像以显示确切值)。

earnings-per-share-growth
SZSE:000915 Earnings Per Share Growth June 20th 2024
SZSE:000915每股收益增长2024年6月20日

We know that Shandong Wit Dyne HealthLtd has improved its bottom line lately, but is it going to grow revenue? You could check out this free report showing analyst revenue forecasts.

我们知道山东华特达因健康股份有限公司的底线最近有所改善,但它是否将增长营业收入?您可以查看此免费报告,其中显示分析师的营业收入预测。

What About Dividends?

那么分红怎么样呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Shandong Wit Dyne HealthLtd the TSR over the last 5 years was 73%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence!

除了衡量股价回报之外,投资者还应考虑总股东回报(TSR)。 TSR是一种回报计算,考虑到现金股利的价值(假设收到的任何股息都是再投资的)以及任何折扣资本募集和分拆的计算价值。可以说,TSR提供了股票产生的回报的更全面的图片。我们注意到,对于山东华特达因健康股份有限公司,过去5年的TSR为73%,优于上述股价回报。毫无疑问,股息支付在很大程度上解释了这种分歧!

A Different Perspective

不同的观点

While it's certainly disappointing to see that Shandong Wit Dyne HealthLtd shares lost 7.5% throughout the year, that wasn't as bad as the market loss of 13%. Of course, the long term returns are far more important and the good news is that over five years, the stock has returned 12% for each year. In the best case scenario the last year is just a temporary blip on the journey to a brighter future. Keeping this in mind, a solid next step might be to take a look at Shandong Wit Dyne HealthLtd's dividend track record. This free interactive graph is a great place to start.

当然,看到山东华特达因健康股份有限公司股票在全年输掉了7.5%的情况肯定让人失望,但这并没有像市场亏损13%那么糟糕。当然,长期回报更为重要,好消息是,在过去的五年中,每年股票回报率为12%。在最好的情况下,去年只是通向更美好未来的暂时闪失。请记住这一点,接下来如果要深入了解山东华特达因健康股份有限公司的股息记录,可以先查看这个免费互动图表。

Of course Shandong Wit Dyne HealthLtd may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

当然,山东华特达因健康股份有限公司可能不是最佳股票购买对象。因此,您可能希望查看这些增长型股票的免费收藏。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所上市的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发